Revealing domain structure through linker-scanning analysis of the murine leukemia virus (MuLV) RNase H and MuLV and human immunodeficiency virus type 1 integrase proteins

Journal of Virology

Volumn 80, Issue 19, 2006, Pages 9497-9510

  Puglia, Jennifer ^a   Wang, Tan ^b   Smith Snyder, Christine ^a   Cote, Marie ^a   Scher, Michael ^a   Pelletier, Joelle N ^d   John, Sinu ^c   Jonsson, Colleen B ^b   Roth, Monica J ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b SOUTHERN RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRASE; MUTANT PROTEIN; PROTEIN MULV; RIBONUCLEASE H; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS VECTOR;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; GENE INSERTION; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN STRUCTURE; PROVIRUS; STOP CODON; STRUCTURAL GENE; STRUCTURE ANALYSIS; VIRUS GENE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; DOGS; GENE EXPRESSION; HIV-1; INTEGRASES; LEUKEMIA VIRUS, MURINE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; RIBONUCLEASE H, CALF THYMUS;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS 1; MOLONEY MURINE LEUKEMIA VIRUS; MURINE LEUKEMIA VIRUS;

EID: 33749016024     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00856-06     Document Type: Article

References (96)

1. Albritton, L. M., L. Tweng, D. Scadden, and J. M. Cunningham. 1989. A putative murine retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 57:659-666.
2. Asante-Appiah, E., S. H. Seeholzer, and A. M. Skalka. 1998. Structural determinants of metal-induced conformational changes in HIV-1 integrase. J. Biol. Chem. 273:35078-35087.
3. Asante-Appiah, E., and A. Skalka. 1997. A metal-induced conformational change and activation of HIV-1 integrase. J. Biol. Chem. 272:16196-16205.
4. Auerbach, M., C. Shu, A. Kaplan, and I. Singh. 2003. Functional characterization of a portion of the Moloney murine leukemia virus gag gene by genetic footprinting. Proc. Natl. Acad. Sci. USA 100:11929-11930.
5. Biery, M. C., F. J. Stewart, A. E. Stellwagen, E. A. Raleigh, and N. L. Craig. 2000. A simple in vitro Tn7-based transposition system with low target site selectivity for genome and gene analysis. Nucleic Acids Res. 28:1067-1077.
6. Bowerman, B., P. O. Brown, J. M. Bishop, and H. E. Varmus. 1989. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 3:469-478.
7. Bujacz, G., J. Alexandratos, Z. Qing, C. Clement-Mella, and A. Wlodawer. 1996. The catalytic domain of human immunodeficiency virus integrase: ordered active site in the F185H mutant. FEBS Lett. 398:175-178.
8. Bujacz, G., M. Jaskolski, J. Alexandratos, A. Wlodawer, G. Merkel, R. A. Katz, and A. M. Skalka. 1995. High-resolution structure of the catalytic domain of avian sarcoma virus integrase. J. Mol. Biol. 253:333-346.
9. Bukrinsky, M. I., N. Sharova, T. L. McDonald, T. Pushkarskaya, W. G. Tarpley, and M. Stevenson. 1993. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. USA 90:6125-6129.
10. Bushman, F. 1995. Targeting retroviral integration. Science 267:1443-1444.
11. Bushman, F. D. 1994. Tethering human immunodeficiency virus 1 integrase to a DNA site directs integration to nearby sequences. Proc. Natl. Acad. Sci. USA 91:9233-9237.
12. Bushman, F. D., A. Engelman, I. Palmer, P. Wingfield, and R. Craigie. 1993. Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding. Proc. Natl. Acad. Sci. USA 90:3428-3432.
13. Bushman, F. D., and M. D. Miller. 1997. Tethering Human immunodeficiency virus type 1 preintegration complexes to target DNA promotes integration at nearby sites. J. Virol. 71:458-464.
14. Cai, M., R. Zheng, M. Caffrey, R. Craigie, G. M. Clore, and A. M. Gronenborn. 1997. Solution structure of the N-terminal zinc binding domain of HIV-1 integrase. Nat. Struct. Biol. 4:567-577.
15. Calmels, B., C. Ferguson, M. O. Laukkanen, R. Adler, M. Faulhaber, H. J. Kim, S. Sellers, P. Hematti, M. Schmidt, C. von Kalle, K. Akagi, R. E. Donahue, and C. E. Dunbar. 2005. Recurrent retroviral vector integration at the MDS1-EVI1 locus in non-human primate hematopoietic cells. Blood 106:2530-2533.
16. Chen, A., I. T. Weber, R. W. Harrison, and J. Leis. 2006. Identification of amino acids in HIV-1 and avian sarcoma virus integrase subsites required for specific recognition of the long terminal repeat ends. J. Biol. Chem. 281: 4173-4182.
17. Chen, H., and A. Engelman. 1998. The barrier-to-autointegration protein is a host factor for HIV type 1 integration. Proc. Natl. Acad. Sci. USA 95: 15270-15274.
18. Chen, J. C.-H., J. Krucinski, L. J. W. Miercke, J. S. Finer-Moore, A. H. Tang, A. D. Leavitt, and R. M. Stroud. 2000. Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding. Proc. Natl. Acad. Sci. USA 97:8233-8238.
19. Chen, Z., Y. Yan, S. Munshi, Y. Li, J. Zugay-Murphy, B. Xu, M. Witmer, P. Felock, A. Wolfe, V. Sardana, E. A. Emini, D. Hazuda, and L. C. Kuo. 2000. X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)-an initial glance of the viral DNA-binding platform. J. Mol. Biol. 296:521-533.
20. Cherepanov, P., A. Ambrosio, S. Rahman, T. Ellenberger, and A. Engelman. 2005. Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. Proc. Natl. Acad. Sci. USA 102:17308-17313.
21. Das, D., and M. Georgiadis. 2004. The crystal structure of the monomeric reverse transcriptase from Moloney murine leukemia virus. Structure (Cambridge) 12:819-829.
22. Dave, U. P., N. A. Jenkins, and N. G. Copeland. 2004. Gene therapy insertional mutagenesis insights. Science 303:333.
23. Davies, J. F., III, Z. Hostomska, Z. Hostomsky, S. R. Jordan, and D. A. Matthews. 1991. Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase. Science 252:88-95.
24. Dayam, R., and N. Neamati. 2004. Active site binding modes of the betadiketoacids: a multi-active site approach in HIV-1 integrase inhibitor design. Bioorg. Med. Chem. 12:6371-6381.
25. Drelich, M., R. Wilhelm, and J. Mous. 1992. Identification of amino acid residues critical for endonuclease and integration activities of HIV-1 IN protein in vitro. Virology 188:459-468.
26. Dyda, F., A. B. Hickman, T. M. Jenkins, A. Engelman, R. Craigie, and D. R. Davies. 1994. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science 266:1981-1986.
27. Engelman, A. 1999. In vivo analysis of retroviral integrase structure and function. Adv. Virus Res. 52:411-426.
28. Farnet, C. M., and W. A. Hazeltine. 1991. Determination of viral proteins present in human immunodeficiency virus type 1 preintegration complex. J. Virol. 65:1910-1915.
29. Fassati, A., and S. P. Goff. 2001. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. J. Virol. 75:3626-3635.
30. Fassati, A., and S. P. Goff. 1999. Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus. J. Virol. 73: 8919-8925.
31. Felkner, R. H., and M. J. Roth. 1992. Mutational analysis of N-linked glycosylation sites of the SU protein of Moloney murine leukemia virus. J. Virol. 66:4258-4264.
32. 2+ ions reveals two divalent metals bound in the active site. J. Biol. Chem. 276:7266-7271.
33. Goff, S. P., P. Traktman, and D. Baltimore. 1981. Isolation and properties of Moloney murine leukemia virus mutants; use of a rapid assay for release of virion reverse transcriptase. J. Virol. 38:239-248.
34. Goldgur, Y., R. Craigie, G. H. Cohen, T. Fujiwara, T. Yoshinaga, T. Fujishita, H. Sugimoto, T. Endo, H. Murai, and D. R. Davies. 1999. Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design. Proc. Natl. Acad. Sci. USA 96:13040-13043.
35. Goldgur, Y., F. Dyda, A. B. Hickman, T. M. Jenkins, R. Craigie, and D. R. Davies. 1998. Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. Proc. Natl. Acad. Sci. USA 95:9150-9154.
36. Goulaouic, H., and S. A. Chow. 1996. Directed integration of viral DNA mediated by fusion proteins consisting of human immunodeficiency virus type 1 integrase and Escherichia coli LexA protein. J. Virol. 70:37-46.
37. Greenwald, J., V. Le, S. Butler, F. Bushman, and S. Choe. 1999. The mobility of an HIV-1 integrase active site loop is correlated with catalytic activity. Biochemistry 38:8892-8898.
38. Hacein-Bey-Abina, S., V. K. C., M. Schmidt, M. P. McCormack, N. Wulffraat, P. Leboulch, A. Lim, C. S. Osborne, R. Pawliuk, E. Morillon, R. Sorensen, A. Forster, P. Fraser, J. I. Cohen, G. de Saint Basile, I. Alexander, U. Wintergerst, T. Frebourg, A. Aurias, D. Stoppa-Lyonnet, S. Romana, I. Radford-Weiss, F. Gross, F. Valensi, E. Delabesse, E. Macintyre, F. Sigaux, J. Soulier, L. E. Leiva, M. Wissler, C. Prinz, T. H. Rabbitts, F. Le Deist, A. Fischer, and M. Cavazzana-Calvo. 2003. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419.
39. Hansen, M. S., and F. D. Bushman. 1997. Human immunodeficiency virus type 2 preintegration complexes: activities in vitro and response to inhibitors. J. Virol. 71:3351-3356.
40. Hehl, E. A., P. Joshi, G. V. Kalpana, and V. R. Prasad. 2004. Interaction between human immunodeficiency virus type 1 reverse transcriptase and integrase proteins. J. Virol. 78:5056-5067.
41. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-371.
42. Hoffman, L., J. Jendrisak, R. Meis, I. Goryshin, and S. Reznikof. 2000. Transposome insertional mutagenesis and direct sequencing of microbial genomes. Genetica 108:19-24.
43. Hyde, C. C., F. D. Bushman, T. C. Mueser, and Z.-N. Yang. 1999. Crystal structure of an active two-domain derivative of rous sarcoma virus integrase. J. Mol. Biol. 296:535-538.
44. Johnson, M. S., M. A. McClure, D. F. Feng, J. Gray, and R. F. Doolittle. 1986. Computer analysis of retroviral pol genes: assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes. Proc. Natl. Acad. Sci. USA 83:7648-7652.
45. Jones, T. A., J. Y. Zou, S. W. Cowan, and M. Kjeldgaard. 1991. Improved methods of building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A. 47:110-119.
46. Jonsson, C. B., G. A. Donzella, E. Gaucan, C. M. Smith, and M. J. Roth. 1996. Functional domains of Moloney murine leukemia virus integrase defined by mutation and complementation analysis. J. Virol. 70:4585-4597.
47. Jonsson, C. B., and M. J. Roth. 1993. Role of the His-Cys finger of Moloney murine leukemia virus integrase protein in integration and disintegration. J. Virol. 67:5562-5571.
48. Katz, R. A., G. Merkel, and A. M. Skalka. 1996. Targeting of retroviral integrase by fusion to a heterologous DNA binding domain: in vitro activities and incorporation of a fusion protein into viral particles. Virology 217:178-190.
49. Kraulis, P. J. 1991. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:946-950.
50. Laurent, L. C., M. N. Olsen, R. A. Crowley, H. Savilahti, and P. O. Brown. 2000. Functional characterization of the human immunodeficiency virus type 1 genome by genetic footprinting. J. Virol. 74:2760-2769.
51. Lee, M. C., J. Deng, J. M. Briggs, and Y. Duan. 2005. Large scale conformational dynamics of the HIV-1 integrase core domain and its catalytic loop mutants. Biophys. J. 88:3133-3146.
52. Lee, M. S., and R. Craigie. 1998. A previously unidentified host protein protects retroviral DNA from autointegration. Proc. Natl. Acad. Sci. USA 95:1528-1533.
53. Li, L., C. M. Farnet, W. F. Anderson, and F. D. Bushman. 1998. Modulation of activity of Moloney murine leukemia virus preintegrative complexes by host factors in vitro. J. Virol. 72:2125-2131.
54. Lim, D. 2001. Functional and structural analysis of the RNaseH domain of the Moloney murine leukemia virus reverse transcriptase. Ph.D. dissertation. Columbia University, New York, N.Y.
55. Lin, C.-W., and A. Engelman. 2003. The barrier-to-autointegration factor is a component of functional human immunodeficiency virus type 1 preintegration complexes. J. Virol. 77:5030-5036.
56. Llano, M., M. Vanegas, O. Fregoso, D. Saenz, S. Chung, M. Peretz, and E. M. Poeschla. 2004. LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J. Virol. 78:9524-9537.
57. Lobel, L. I., and S. P. Goff. 1984. Construction of mutants of Moloney murine leukemia virus by suppressor-linker insertion mutagenesis: positions of viable insertion mutations. Proc. Natl. Acad. Sci. USA 81:4149-4153.
58. Lu, R., H. Z. Ghory, and A. Engelman. 2005. Genetic analyses of conserved residues in the carboxyl-terminal domain of human immunodeficiency virus type 1 integrase. J. Virol. 79:10356-10368.
59. Lu, R., A. Limon, E. Devroe, P. A. Silver, P. Cherepanov, and A. Engelman. 2004. Class II integrase mutants with changes in putative nuclear localization signals are primarily blocked at a postnuclear entry step of human immunodeficiency virus type 1 replication. J. Virol. 78:12735-12746.
60. Lu, R., A. Limon, H. Z. Ghory, and A. Engelman. 2005. Genetic analyses of DNA-binding mutants in the catalytic core domain of human immunodeficiency virus type 1 integrase. J. Virol. 79:2493-2505.
61. Lutzke, R. A. P., and R. H. A. Plasterk. 1998. Structure-based mutational analysis of the C-terminal DNA-binding domain of human immunodeficiency virus type 1 integrase: critical residues for protein oligomerization and DNA binding. J. Virol. 72:4841-4848.
62. McClure, M. A., M. S. Johnson, D.-F. Feng, and R. F. Doolittle. 1988. Sequence comparisons of retroviral proteins: relative rates of change and general phylogeny. Proc. Natl. Acad. Sci. USA 85:2469-2473.
63. McCormack, M., A. Forster, L. Drynan, R. Pannell, and T. H. Rabbits. 2003. The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development. Mol. Cell. Biol. 23:9003-9013.
64. McCutchan, J. H., and J. S. Pagano. 1968. Enhancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran. J. Natl. Cancer Inst. 41:351-357.
65. Merrit, E. A., and D. J. Bacon. 1997. Raster3d: photorealistic molecular graphics. Methods Enzymol. 227:505-524.
66. Miller, M. D., C. M. Farnet, and F. D. Bushman. 1997. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 71:5382-5390.
67. Nermut, M. V., and A. Fassati. 2003. Structural analyses of purified human immunodeficiency virus type 1 intracellular reverse transcription complexes. J. Virol. 77:8196-8206.
68. O'Reilly, L., and M. J. Roth. 2000. Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses. J. Virol. 74:899-913.
69. Oz-Gleenberg, I., O. Avidan, Y. Goldgur, A. Herschhorn, and A. Hizi. 2005. Peptides derived from the reverse transcriptase of human immunodeficiency virus type 1 as novel inhibitors of the viral integrase. J. Biol. Chem. 280: 21987-21996.
70. Pearlman, D. A., D. A. Case, J. W. Caldwell, W. R. Ross, T. E. Cheatham III, S. DeBolt, D. Ferguson, G. Seibel, P. Kollman, and P. Amber. 1995. AMBER, a computer program for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to elucidate the structure and energies of molecules. Comput. Phys. Commun. 91:1-41.
71. Petyuk, V., J. McDermott, M. Cook, and B. Sauer. 2004. Functional mapping of Cre recombinase by pentapeptide insertional mutagenesis. J. Biol. Chem. 279:37040-37048.
72. Podtelezhnikov, A., K. Gao, F. Bushman, and J. McCammon. 2003. Modeling HIV-1 integrase complexes based on their hydrodynamic properties. Biopolymers 68:110-120.
73. Quinonez, R., I. Sinha, I. R. Singh, and R. E. Sutton. 2003. Genetic footprinting of the HIV co-receptor CCR5: delineation of surface expression and viral entry determinants. Virology 307:98-115.
74. Roth, M. J. 1991. Mutational analysis of the carboxyl terminus of the Moloney murine leukemia virus integration protein. J. Virol. 65:2141-2145.
75. Roth, M. J., P. Schwartzberg, N. Tanese, and S. P. Goff. 1990. Analysis of mutations in the integration function of Moloney murine leukemia virus: effects on DNA binding and cutting. J. Virol. 64:4709-4717.
76. Roth, M. J., N. Tanese, and S. P. Goff. 1988. Gene product of Moloney murine leukemia virus required for proviral integration is a DNA-binding protein. J. Mol. Biol. 203:131-139.
77. Roth, M. J., N. Tanese, and S. P. Goff. 1985. Purification and characterization of murine retroviral reverse transcriptase expressed in Escherichia coli. J. Biol. Chem. 260:9326-9335.
78. Rothenberg, S. M., M. N. Olsen, L. C. Laurent, R. A. Crowley, and P. O. Brown. 2001. Comprehensive mutational analysis of the Moloney murine leukemia virus envelope protein. J. Virol. 75:11851-11862.
79. Schwartzberg, P., M. Roth, N. Tanese, and S. Goff. 1993. Analysis of a temperature-sensitive mutation affecting the integration protein of Moloney murine leukemia virus. Virology 192:673-678.
80. Seamon, J. A., M. Adams, S. Sengupta, and M. J. Roth. 2000. Differential effects of C-terminal molecular tagged integrase on replication competent Moloney-murine leukemia virus. Virology 274:412-419.
81. Seamon, J. A., C. Miller, K. S. Jones, and M. J. Roth. 2002. Inserting nuclear targeting signals onto a replication-competent M-MuLV affects viral export and is not sufficient for cell cycle independent infection. J. Virol. 76:8475-8484.
82. Shinnick, T. M., R. A. Lerner, and J. G. Sutcliffe. 1981. Nucleotide sequence of Moloney murine leukaemia virus. Nature 293:543-548.
83. Singh, I. R., R. A. Crowley, and P. O. Brown. 1997. High-resolution functional mapping of a cloned gene by genetic footprinting. Proc. Natl. Acad. Sci. USA 94:1304-1309.
84. Tan, W., K. Zhu, D. J. Segal, I. Carlos F. Barbas, and S. A. Chow. 2004. Fusion proteins consisting of human immunodeficiency virus type 1 integrase and the designed polydactyl zinc finger protein E2C direct integration of viral DNA into specific sites. J. Virol. 78:1301-1313.
85. Tanese, N., and S. P. Goff. 1988. Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities. Proc. Natl. Acad. Sci. USA 85:1777-1781.
86. Tanese, N., A. Telesnitsky, and S. P. Goff. 1991. Abortive reverse transcription by mutants of Moloney murine leukemia virus deficient in the reverse transcriptase-associated RNase H function. J. Virol. 65:4387-4397.
87. Wang, J.-Y., H. Ling, W. Yang, and R. Craigie. 2001. Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein. EMBO J. 20:7333-7343.
88. Wang, T., M. Balakrishnan, and C. B. Jonsson. 1999. Major and minor groove contacts in retroviral integrase-LTR interactions. Biochemistry 38: 3624-3632.
89. Wilhelm, M., and F.-X. Wilhelm. 2005. Role of integrase in reverse transcription of the Saccharomyces cerevisiae retrotransposon Ty1. Eukaryot. Cell 4:1057-1065.
90. Wu, W., H. Lui, L. Xiao, J. A. Conway, E. Hehl, G. V. Kalpana, V. Prasad, and J. C. Kappes. 1999. Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex. J. Virol. 73:2126-2135.
91. Yang, F., O. Leon, N. J. Greenfield, and M. J. Roth. 1999. Functional interactions of the HHCC domain of Moloney murine leukemia virus integrase revealed by non-overlapping complementation and zinc dependent dimerization. J. Virol. 73:1809-1817.
92. Yang, F., J. A. Seamon, and M. J. Roth. 2001. Mutational analysis of the N-terminus of Moloney murine leukemia virus integrase. Virology 291: 32-45.
93. Yang, W., W. A. Hendrickson, R. J. Crouch, and Y. Satow. 1990. Structure of ribonuclease H phased at 2 Å resolution by MAD analysis of the selenomethionyl protein. Science 249:1398-1405.
94. Yang, Z. N., T. C. Mueser, F. D. Bushman, and C. C. Hyde. 2000. Crystal structure of an active two-domain derivative of Rous Sarcoma virus integrase. J. Mol. Biol. 296:535-548.
95. Yi, J., J. Arthur, R. Dunbrack, Jr., and A. Skalka. 2000. An inhibitory monoclonal antibody binds at the turn of the helix-turn-helix motif in the N-terminal domain of HIV-1 integrase. J. Biol. Chem. 275:38739-38748.
96. Zhu, K., C. Dobard, and S. A. Chow. 2004. Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase. J. Virol. 78:5045-5055.